Short Term Observational Study in DEB Patients
NCT02178969 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 29
Last updated 2021-03-17
Summary
The purpose of this study is to better understand disease extent and to identify appropriate methodologies to evaluate (dystrophic epidermolysis bullosa) DEB in a quantitative and qualitative manner.
Conditions
- Dystrophic Epidermolysis Bullosa
Sponsors & Collaborators
-
Shire
lead INDUSTRY
Principal Investigators
-
Study Director · Takeda
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-06-24
- Primary Completion
- 2015-02-23
- Completion
- 2015-02-23
Countries
- United States
- Australia
- Austria
- Czechia
- France
- Germany
- Italy
Study Locations
More Related Trials
-
Genotype-phenotype Correlation in Junctional Epidermolysis Bullosa
NCT04727268 ·Status: UNKNOWN
-
Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene
NCT05529134 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Observational Study of a Cohort of Patients With Hereditary Epidermolysis Bullosa
NCT04217538 ·Status: COMPLETED
-
Artificial Intelligence Patient App for RDEB SCCs
NCT05843994 ·Status: ACTIVE_NOT_RECRUITING
-
The Natural History of Wounds in Patients With Dystrophic Epidermolysis Bullosa (DEB)
NCT04214002 ·Status: WITHDRAWN
-
Evaluation of D-Fi for the Treatment of Wounds Due to DEB
NCT06892639 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Extension Study to PTR-01-002 (A Study in Recessive Dystrophic Epidermolysis Bullosa (RDEB) Patients Previously Treated With PTR-01)
NCT05143190 ·Status: COMPLETED ·Phase: PHASE2
-
Molecular Signatures of Cutaneous Squamous Cell Carcinoma During Recessive Dystrophic Epidermolysis Bullosa
NCT04285294 ·Status: UNKNOWN
-
A Study of PTR-01 in Recessive Dystrophic Epidermolysis Bullosa
NCT04599881 ·Status: COMPLETED ·Phase: PHASE2
-
Survey to Identify Burdens and Unmet Needs of Patients With Epidermolysis Bullosa
NCT03158662 ·Status: COMPLETED
-
A Phase 1/2 Trial of PTR-01 in Adult Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
NCT03752905 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa
NCT04213261 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB)
NCT02810951 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Phase II Pilot Study of Extracorporeal Phototherapy for Epidermolysis Bullosa Acquisita
NCT00004359 ·Status: COMPLETED ·Phase: PHASE2
-
Recessive Dystrophic Epidermolysis Bullosa Screening for Possible Gene Transfer
NCT00533572 ·Status: TERMINATED
-
Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa
NCT00904163 ·Status: COMPLETED
-
Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis
NCT03585946 ·Status: WITHDRAWN
-
Computational Drug Repurposing for All EBS Cases
NCT03269474 ·Status: RECRUITING
-
A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy
NCT00936546 ·Status: COMPLETED ·Phase: PHASE2
-
Mesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis Bullosa
NCT02323789 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Intravenous Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB)
NCT03392909 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa
NCT05157958 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa
NCT03578029 ·Status: TERMINATED ·Phase: PHASE2
-
Addressing Inequity in Dermatology
NCT06056648 ·Status: RECRUITING
-
A Study to Explore Safety, Pharmacokinetics, and Early Clinical Signal of Efficacy of DS-2325a in Patients With Netherton Syndrome
NCT05979831 ·Status: TERMINATED ·Phase: PHASE1/PHASE2